Oldest old patients aged 85 years and over are at risk of experiencing potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) across transitions of care. Geriatricians also face enormous challenges in prescribing medications for these patients.
A mixed-methods, sequential explanatory design was undertaken of electronic medical records and semi-structured interviews with geriatricians at a public teaching hospital. Data were collected at four time points using the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Screening Tool to Alert doctors to the Right Treatment (START).
Of 249 patients, the prevalence of at least 1 PIM varied between 36.9 and 51.0%, while the prevalence of at least 1 PPO varied between 36.9 and 44.6%. The most common PIM was use of proton pump inhibitors while the most common PPO was omission of vitamin D supplements in housebound patients or patients experiencing falls. Poisson regression analysis showed that PIMs were significantly associated with use of mobility aids, 1.430 (95% CI 1.109–1.843, p = 0.006), and number of medications prescribed at admission, 1.083 (95% CI 1.058–1.108, p < 0.001). PPOs were significantly associated with comorbidities, 1.172 (95% CI 1.073–1.280, p < 0.001), medications prescribed at admission, 0.989 (95% CI 0.978–0.999, p = 0.035), and length of stay, 1.004 (95% CI 1.002–1.006, p < 0.001). Geriatrician interviews (N = 9) revealed medication-related, health professional-related and patient-related challenges with managing medications.
Inappropriate prescribing is common in oldest old patients. Greater attention is needed on actively de-prescribing medications that are not beneficial and commencing medications that would be advantageous. Tailored strategies for improving prescribing practices are needed.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
United Nations (2015) World population ageing. United Nations, New York
Ortman J, Velkoff V, Hogan H (2014) An aging nation: the older population in the United States. Department of Commerce, US Census Bureau, Washington, DC, US
Galvin R, Moriarty F, Cousins G et al (2014) Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol 70:599–606. https://doi.org/10.1007/s00228-014-1651-8
Hamilton HJ, Gallagher P, O’Mahony D (2009) Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 9 (5):https://doi.org/10.1186/1471-2318-1189-1185
Hamilton H, Gallagher P, Ryan C et al (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171:1013–1019
Runciman WB, Roughead EE, Semple SJ et al (2003) Adverse drug events and medication errors in Australia. Int J Qual Health Care 15:i49–i59
Sakuma M, Morimoto T (2011) Adverse drug events due to potentially inappropriate medications. Arch Intern Med 171:1959. https://doi.org/10.1001/archinternmed.2011.553
Yayla M, Bilge U, Binen E et al (2013) The use of START/STOPP criteria for elderly patients in primary care. Sci World J. https://doi.org/10.1155/2013/165873
Gallagher P, Ryan C, Byrne S et al (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72–83
O’Mahony D, O’Sullivan D, Byrne S et al (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44:213–218. https://doi.org/10.1093/ageing/afu145
Hill-Taylor B, Hayden J, Byrne S et al (2013) Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther 38:360–372
Elliott R, Stehlik P (2013) Identifying inappropriate prescribing for older people. J Pharmac Pract Res 43:312–319
Charlson M, Pompei P, Ales K et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Manias E, Kusljic S, Berry C et al (2015) Use of the Screening Tool of Older Person’s Prescriptions (STOPP) in older people admitted to an Australian hospital. Aust J Ageing 34:15–20
Ble A, Masoli JAH, Barry HE et al (2015) Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12. BMC Geriatr 15:146–146. https://doi.org/10.1186/s12877-015-0143-8
Wauters M, Elseviers M, Vaes B et al (2016) Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol 82:1382–1392. https://doi.org/10.1111/bcp.13055
Lai X, Zhu H, Huo X, Li Z (2018) Polypharmacy in the oldest old (≥ 80 years of age) patients in China: a cross-sectional study. BMC Geriatr 18:64–64. https://doi.org/10.1186/s12877-018-0754-y
San-José A, Agustí A, Vidal X et al (2015) Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatr 15:42–42. https://doi.org/10.1186/s12877-015-0038-8
Dalleur O, Boland B, De Groot A et al (2015) Detection of potentially inappropriate prescribing in the very old: cross-sectional analysis of the data from the BELFRAIL observational cohort study. BMC Geriatr 15:1
San-José A, Agustí A, Vidal X et al (2014) Original article: Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing. Eur J Intern Med 25:710–716. https://doi.org/10.1016/j.ejim.2014.07.011
Wauters M, Elseviers M, Vaes B et al (2016) Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalisation in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.13055
Wahab MSA, Nyfort-Hansen K, Kowalski SR (2012) Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria. Int J Clin Pharm 34:855–862. https://doi.org/10.1007/s11096-012-9681-8
Manias E, Kusljic S, Lam D-L (2015) Use of the Screening Tool of Older Persons’ Prescriptions (STOPP) and the Screening Tool to Alert doctors to the Right Treatment (START) in hospitalised older people. Aust J Ageing 34:252–258. https://doi.org/10.1111/ajag.12186
Frankenthal D, Lerman Y, Lerman Y (2015) The impact of hospitalization on potentially inappropriate prescribing in an acute medical geriatric division. Int J Clin Pharm 37:60–67. https://doi.org/10.1007/s11096-014-0040-9
Blanco Reina E, Ariza Zafra G, Ocaña Riola R et al (2015) Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related? Eur J Clin Pharmacol 71:199–207
Di Giorgio C, Provenzani A, Polidori P (2016) Potentially inappropriate drug prescribing in elderly hospitalized patients: an analysis and comparison of explicit criteria. Int J Clin Pharm 38:462–468. https://doi.org/10.1007/s11096-016-0284-7
Miller G, Wong C, Pollack A (2015) Gastro-oesophageal reflux disease (GORD) in Australian general practice patients. Aust Fam Phys 44:701–704
Wallerstedt SM, Fastbom J, Linke J et al (2017) Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection—a cross-sectional population-based study. Pharmacoepidemiol Drug Saf 26:9–16. https://doi.org/10.1002/pds.4135
Rane PP, Guha S, Chatterjee S et al Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US. Res Soc Adm Pharm 13 (2):358–363. https://doi.org/10.1016/j.sapharm.2016.02.012
Eusebi LH, Rabitti S, Artesiani ML et al (2017) Proton pump inhibitors: Risks of long-term use. J Gastroenterol Hepatol 32:1295–1302. https://doi.org/10.1111/jgh.13737
Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469. https://doi.org/10.1136/bmj.326.7387.469
Broe KE, Chen TC, Weinberg J et al (2007) A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 55:234–239. https://doi.org/10.1111/j.1532-5415.2007.01048.x
de Groote P, Isnard R, Assyag P et al (2007) Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 9:1205–1211. https://doi.org/10.1016/j.ejheart.2007.09.008
Napolitano F, Izzo M, Di Giuseppe G et al (2013) Frequency of inappropriate medication prescription in hospitalized elderly patients in Italy. PLoS One 8:e82359–e82359
Wimmer BC, Bell JS, Fastbom J et al (2016) Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study. Ann Pharmacother 50:89–95. https://doi.org/10.1177/1060028015621071
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For the retrospective clinical audit of electronic medical records, formal consent was not required. For the semi-structured interviews with geriatricians, informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Manias, E., Maier, A. & Krishnamurthy, G. Inappropriate medication use in hospitalised oldest old patients across transitions of care. Aging Clin Exp Res 31, 1661–1673 (2019). https://doi.org/10.1007/s40520-018-01114-1
- Oldest old
- Inappropriate medication
- Potentially inappropriate medication
- Potential prescribing omission